My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

BELLUS Health Inc. - Common Shares (NQ:BLU)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Jun 28, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about BELLUS Health Inc. - Common Shares

< Previous 1 2 Next >

BELLUS Health Shares Slide On Public Offering Of Shares In Canada And US ↗

July 13, 2022

Via Benzinga

BELLUS Health Announces FDA End-of-Phase 2 Meeting For Refractory Chronic Cough Program ↗

July 12, 2022

Via Benzinga

The Week In Charts: How To Make Money While Waiting For Core Trend Trades ↗

July 02, 2022

The real money is in the longer-term core trend trades. However, sometimes those opportunities can be few and far between. This is especially true in a bear market.

Via Talk Markets

4 Biotech Stocks With Bright Prospects To Buy Amid Recovery ↗

June 11, 2022

New drug approvals, acquisitions, and other pipeline developments are back in the spotlight in the biotech industry, following the focus on the development of vaccines and antibody treatments for...

Via Talk Markets

The Daily Biotech Pulse: Pfizer-BioNTech's COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio's AP-013 Trial Under Independent Investigation ↗

May 17, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Understanding BELLUS Health's Unusual Options Activity ↗

August 12, 2021

On Thursday, shares of BELLUS Health (NASDAQ:BLU) saw unus...

Via Benzinga

The Daily Biotech Pulse: Mesoblast, Novartis Sever COVID-19 Treatment Partnerships, Sigilon To Reduce Workforce, ASH Presentations Move Stocks ↗

December 14, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Vaccitech To Buy Avidea For $40M Vaccitech plc (NASDAQ: VACC) announced that...

Via Benzinga

58 Biggest Movers From Yesterday ↗

December 14, 2021

Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares jumped 80.4% to close at $90.08 on Monday. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-...

Via Benzinga

Mid-Afternoon Market Update: Dow Tumbles Over 200 Points; BELLUS Health Shares Spike Higher ↗

December 13, 2021

Toward the end of trading Monday, the Dow traded down 0.67% to 35,728.62 while the NASDAQ fell 0.92% to 15,487.41. The S&P also fell, dropping 0.58% to 4,684.47. The U.S. has...

Via Benzinga

Mid-Day Market Update: Nasdaq Drops Over 100 Points; Foghorn Therapeutics Shares Surge ↗

December 13, 2021

Midway through trading Monday, the Dow traded down 0.81% to 35,679.10 while the NASDAQ fell 0.78% to 15,509.01. The S&P also fell, dropping 0.67% to 4,680.56. The U.S. has the...

Via Benzinga

Topics Stocks

40 Stocks Moving In Monday's Mid-Day Session ↗

December 13, 2021

Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares climbed 83.4% to $91.52. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-cash transaction....

Via Benzinga

ARNA Stock Alert: The Pfizer Deal That Has Arena Pharmaceuticals Rocketing Today ↗

December 13, 2021

Arena Pharmaceuticals (ARNA) stock is flying higher on Monday thanks to a huge $6.7 billion acquisition deal with Pfizer (PFE).

Via InvestorPlace

Here's Why Bellus Health Is Jumping Higher Today ↗

December 13, 2021

A phase 2 trial with the company's chronic-cough candidate hit its primary endpoint.

Via The Motley Fool

NES, WTTR: The Deal That Has Penny Stock Nuverra Environmental Solutions Skyrocketing Today ↗

December 13, 2021

Nuverra Environmental (NES) stock is surging higher on Monday following news of a massive deal with Select Energy Services (WTTR).

Via InvestorPlace

BLU Stock Alert: The Study Data That Has BELLUS Health Blasting Higher Today ↗

December 13, 2021

BELLUS Health (BLU) stock is rocketing higher on Monday and it's all thanks to data from a Phase 2b clinical trial of BLU-5937.

Via InvestorPlace

Mid-Morning Market Update: Markets Open Lower; Pfizer To Acquire Arena Pharmaceuticals ↗

December 13, 2021

Following the market opening Monday, the Dow traded down 0.65% to 35,736.04 while the NASDAQ fell 0.26% to 15,590.13. The S&P also fell, dropping 0.46% to 4,690.48. The U.S....

Via Benzinga

Topics Stocks

The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré ↗

December 07, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Acadia Announces Positive Phase 3 Data For Trofinetide In Rett Syndrome...

Via Benzinga

The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug ↗

September 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks...

Via Benzinga

The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs ↗

September 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC)...

Via Benzinga

46 Biggest Movers From Yesterday ↗

September 15, 2021

Gainers Communications Systems, Inc. (NASDAQ: JCS) jumped 39.4% to close at $9.41 on Tuesday as the company declared a special dividend of $3.50 per share. Onion Global Limited...

Via Benzinga

Why BELLUS Health Is Trading Higher Today ↗

September 14, 2021

BELLUS Health (NASDAQ:BLU) shares are trading higher. The company on Monday announced interim analysis from the Phase 2b SOOTHE trial of BLU-5937 in refractor chronic...

Via Benzinga

Mid-Afternoon Market Update: Dow Tumbles 300 Points; Communications Systems Shares Climb ↗

September 14, 2021

Toward the end of trading Tuesday, the Dow traded down 0.87% to 34,565.88 while the NASDAQ fell 0.46% to 15,035.39. The S&P also fell, dropping 0.60% to 4,441.76. The U.S. has...

Via Benzinga

Topics Stocks

Mid-Day Market Update: FuelCell Energy Jumps After Q3 Results; RedHill Biopharma Shares Slide ↗

September 14, 2021

Midway through trading Tuesday, the Dow traded down 0.49% to 34,698.16 while the NASDAQ fell 0.05% to 15,098.38. The S&P also fell, dropping 0.24% to 4,458.05. The U.S. has...

Via Benzinga

Topics Stocks

36 Stocks Moving In Tuesday's Mid-Day Session ↗

September 14, 2021

Gainers FuelCell Energy, Inc. (NASDAQ: FCEL) shares jumped 26% to $7.08 after the company reported better-than-expected Q3 results. BELLUS Health Inc. (NASDAQ: BLU) shares...

Via Benzinga

Mid-Morning Market Update: Markets Mostly Lower; US Annual Inflation Rate Slows to 5.3% in August ↗

September 14, 2021

Following the market opening Tuesday, the Dow traded down 0.26% to 34,778.27 while the NASDAQ rose 0.01% to 15,106.84. The S&P also fell, dropping 0.20% to 4,459.89. The U.S....

Via Benzinga

Topics Stocks

The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout ↗

September 14, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13) Abbott Laboratories (NYSE...

Via Benzinga

72 Biggest Movers From Yesterday ↗

September 14, 2021

Gainers aTyr Pharma, Inc. (NASDAQ: LIFE) jumped 67% to settle at $9.15 on Monday as the company announced positive results from its Phase 1b/2a trial evaluating its lead...

Via Benzinga

What's Going On With BELLUS Health's Stock Today? ↗

September 13, 2021

BELLUS Health Inc (NASDAQ: BLU) is trading higher Monday after the company announced interim analysis from the Phase 2b SOOTHE trial of BLU-5937 in refractory chronic cough....

Via Benzinga

BELLUS Health Stock Shines After Refractory Chronic Cough Trial Data ↗

September 13, 2021

BELLUS Health Inc (NASDAQ: BLU) has announced a positive interim analysis from Phase 2b SOOTHE trial of BLU-5937 for refractory chronic cough (RCC). BLU-5937, the...

Via Benzinga

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.